Joe Biden wants diabetes drugs that aid weight loss and treat obesity, such as Wegovy, to fall under Medicare and Medicaid.

The U.S. pharmaceutical industry is pushing to revamp the new law that allows Medicare to negotiate prices for its costliest ...

More than seven million additional Americans could get coverage for popular drugs such as Zepbound and Wegovy under the ...

Millions of Americans would be eligible to have popular drugs used for weight loss like Wegovy or Ozempic covered by Medicare ...

The Biden administration has proposed a new rule to “significantly” expand coverage of anti-obesity medications for Americans ...

With fewer Part D plans and a $2,000 out-of-pocket cap, beneficiaries must rethink their Medicare drug coverage for 2025.

Robert Powell: Are you about to enroll in Medicare and trying to decide whether to sign up for a Medicare Advantage plan or ...

Changes to Medicare in 2025 include a cap on out-of-pocket prescription drug costs, changes to mental health care services, ...

The CMS estimated that coverage of the weight-loss drugs will cost the federal government about $25 billion for Medicare and ...

Medicare's star ratings system also accounts for enrollee turnaround. A plan that loses a lot of members in a given year will ...

Millions of Americans with obesity would be eligible to have popular drugs used for weight loss like Wegovy or Ozempic ...

The feds say Dr. Rajesh Bindal lied about surgeries he never performed at Texas Spine & Neurosurgery Center P.A. on the ...